引用本文:彭 巍(综述),冯国生(审校).小细胞肺癌维持治疗的研究进展[J].中国临床新医学,2012,5(8):788-791.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1744次   下载 1205 本文二维码信息
码上扫一扫!
分享到: 微信 更多
小细胞肺癌维持治疗的研究进展
彭 巍(综述),冯国生(审校)
530021 南宁,广西壮族自治区人民医院肿瘤中心化疗一区
摘要:
[摘要] 小细胞肺癌一线治疗缓解后复发较快,复发后易出现多药耐药,以致部分患者二线治疗的敏感性较差。近年来一些化疗药及新的靶向药物被运用于小细胞肺癌维持治疗的研究,但维持治疗在小细胞肺癌治疗中的作用及地位仍是众多学者争论的焦点。该文综述了近年来小细胞肺癌维持治疗的研究进展。
关键词:  小细胞肺癌  维持治疗
DOI:10.3969/j.issn.1674-3806.2012.08.37
分类号:R 734.2
基金项目:
Research progress on maintenance therapy of small cell lung cancer
PENG Wei,FENG Guo-sheng
Department of Chemotherapy, the People′s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,China
Abstract:
[Abstract] Small cell lung cancer relapses after first-line chemotherapy quickly, it induces multidrug resistance after recurrence easily,so that part of the patients is less sensitive to the second-line treatment. In recent years,some chemotherapies and new targeted drugs were used in research of maintenance therapy of small cell lung cancer, but the function and status of maintenance therapy in small cell lung cancer are still debated. In this paper, the research progress on the maintenance therapy of small cell lung cancer is reviewed.
Key words:  Small cell lung cancer  Maintenance therapy